請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21426
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 李心予 | |
dc.contributor.author | Kuan-Hung Lin | en |
dc.contributor.author | 林貫浤 | zh_TW |
dc.date.accessioned | 2021-06-08T03:33:45Z | - |
dc.date.copyright | 2019-08-07 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-06 | |
dc.identifier.citation | 1. Orkin SH, Zon LI: Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132(4):631-644.
2. Palis J, Robertson S, Kennedy M, Wall C, Keller G: Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development (Cambridge, England) 1999, 126(22):5073-5084. 3. Palis J: Ontogeny of erythropoiesis. Current opinion in hematology 2008, 15(3):155-161. 4. Lacaud G, Kouskoff V: Hemangioblast, hemogenic endothelium, and primitive versus definitive hematopoiesis. Experimental hematology 2016. 5. Murray PDF: The Development in vitro of the Blood of the Early Chick Embryo. Proceedings of the Royal Society of London Series B, Containing Papers of a Biological Character 1932, 111(773):497-521. 6. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G: A common precursor for hematopoietic and endothelial cells. Development (Cambridge, England) 1998, 125(4):725-732. 7. Nishikawa SI, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H: Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development (Cambridge, England) 1998, 125(9):1747-1757. 8. Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, Yang Y, Becker MS, Zanetta L, Dejana E, Gasson JC et al: Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell stem cell 2008, 3(6):625-636. 9. Jaffredo T, Gautier R, Eichmann A, Dieterlen-Lievre F: Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development (Cambridge, England) 1998, 125(22):4575-4583. 10. Eilken HM, Nishikawa S, Schroeder T: Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature 2009, 457(7231):896-900. 11. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, Lacaud G: The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009, 457(7231):892-895. 12. Fraser ST, Ogawa M, Yu RT, Nishikawa S, Yoder MC, Nishikawa S: Definitive hematopoietic commitment within the embryonic vascular endothelial-cadherin(+) population. Experimental hematology 2002, 30(9):1070-1078. 13. Ema M, Yokomizo T, Wakamatsu A, Terunuma T, Yamamoto M, Takahashi S: Primitive erythropoiesis from mesodermal precursors expressing VE-cadherin, PECAM-1, Tie2, endoglin, and CD34 in the mouse embryo. Blood 2006, 108(13):4018-4024. 14. Costa G, Kouskoff V, Lacaud G: Origin of blood cells and HSC production in the embryo. Trends in immunology 2012, 33(5):215-223. 15. Lux CT, Yoshimoto M, McGrath K, Conway SJ, Palis J, Yoder MC: All primitive and definitive hematopoietic progenitor cells emerging before E10 in the mouse embryo are products of the yolk sac. Blood 2008, 111(7):3435-3438. 16. Vogeli KM, Jin S-W, Martin GR, Stainier DYR: A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula. Nature 2006, 443:337. 17. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, Lacaud G: The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009, 457:892. 18. Medvinsky AL, Samoylina NL, Muller AM, Dzierzak EA: An early pre-liver intraembryonic source of CFU-S in the developing mouse. Nature 1993, 364(6432):64-67. 19. Ivanovs A, Rybtsov S, Welch L, Anderson RA, Turner ML, Medvinsky A: Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. The Journal of experimental medicine 2011, 208(12):2417-2427. 20. Corbel C, Salaun J, Belo-Diabangouaya P, Dieterlen-Lievre F: Hematopoietic potential of the pre-fusion allantois. Developmental biology 2007, 301(2):478-488. 21. Zeigler BM, Sugiyama D, Chen M, Guo Y, Downs KM, Speck NA: The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential. Development (Cambridge, England) 2006, 133(21):4183-4192. 22. Garcia-Porrero JA, Godin IE, Dieterlen-Lievre F: Potential intraembryonic hemogenic sites at pre-liver stages in the mouse. Anatomy and embryology 1995, 192(5):425-435. 23. North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M, Marin-Padilla M, Speck NA: Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development (Cambridge, England) 1999, 126(11):2563-2575. 24. North TE, Stacy T, Matheny CJ, Speck NA, de Bruijn MFTR: Runx1 Is Expressed in Adult Mouse Hematopoietic Stem Cells and Differentiating Myeloid and Lymphoid Cells, But Not in Maturing Erythroid Cells. Stem cells (Dayton, Ohio) 2004, 22(2):158-168. 25. Pazianos G, Uqoezwa M, Reya T: The elements of stem cell self-renewal: a genetic perspective. BioTechniques 2003, 35(6):1240-1247. 26. Wilson A, Laurenti E, Trumpp A: Balancing dormant and self-renewing hematopoietic stem cells. Current opinion in genetics & development 2009, 19(5):461-468. 27. Schofield R: The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood cells 1978, 4(1-2):7-25. 28. Asada N, Takeishi S, Frenette PS: Complexity of bone marrow hematopoietic stem cell niche. International journal of hematology 2017, 106(1):45-54. 29. Omatsu Y, Sugiyama T, Kohara H, Kondoh G, Fujii N, Kohno K, Nagasawa T: The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33(3):387-399. 30. Zhu J, Garrett R, Jung Y, Zhang Y, Kim N, Wang J, Joe GJ, Hexner E, Choi Y, Taichman RS et al: Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 2007, 109(9):3706-3712. 31. Song K, Li L, Wang Y, Liu T: Hematopoietic stem cells: multiparameter regulation. Human cell 2016, 29(2):53-57. 32. da Silva CL, Goncalves R, Crapnell KB, Cabral JM, Zanjani ED, Almeida-Porada G: A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Experimental hematology 2005, 33(7):828-835. 33. Lui WC, Chan YF, Chan LC, Ng RK: Cytokine combinations on the potential for ex vivo expansion of murine hematopoietic stem cells. Cytokine 2014, 68(2):127-132. 34. Yeoh JS, van Os R, Weersing E, Ausema A, Dontje B, Vellenga E, de Haan G: Fibroblast growth factor-1 and -2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures. Stem cells (Dayton, Ohio) 2006, 24(6):1564-1572. 35. Kovtonyuk LV, Manz MG, Takizawa H: Enhanced thrombopoietin but not G-CSF receptor stimulation induces self-renewing hematopoietic stem cell divisions in vivo. Blood 2016, 127(25):3175-3179. 36. Wang C, Zhang B, Wang S, Zhang J, Liu Y, Wang J, Fan Z, Lv Y, Zhang X, He L et al: Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation. Scientific reports 2015, 5:12993. 37. Khodadi E, Shahrabi S, Shahjahani M, Azandeh S, Saki N: Role of stem cell factor in the placental niche. Cell and tissue research 2016, 366(3):523-531. 38. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ: SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121(7):1109-1121. 39. Ramalingam P, Poulos MG, Butler JM: Regulation of the hematopoietic stem cell lifecycle by the endothelial niche. Current opinion in hematology 2017, 24(4):289-299. 40. Asada N, Kunisaki Y, Pierce H, Wang Z, Fernandez NF, Birbrair A, Ma'ayan A, Frenette PS: Differential cytokine contributions of perivascular haematopoietic stem cell niches. Nature cell biology 2017, 19(3):214-223. 41. Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K et al: Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 2013, 502(7473):637-643. 42. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS: Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452(7186):442-447. 43. Nakamura-Ishizu A, Takubo K, Fujioka M, Suda T: Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin. Biochemical and biophysical research communications 2014, 454(2):353-357. 44. Zhao M, Perry JM, Marshall H, Venkatraman A, Qian P, He XC, Ahamed J, Li L: Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nature medicine 2014, 20(11):1321-1326. 45. Nilsson SK, Johnston HM, Coverdale JA: Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001, 97(8):2293-2299. 46. Silberstein L, Goncalves KA, Kharchenko PV, Turcotte R, Kfoury Y, Mercier F, Baryawno N, Severe N, Bachand J, Spencer JA et al: Proximity-Based Differential Single-Cell Analysis of the Niche to Identify Stem/Progenitor Cell Regulators. Cell stem cell 2016, 19(4):530-543. 47. Asada N, Katayama Y: Regulation of hematopoiesis in endosteal microenvironments. International journal of hematology 2014, 99(6):679-684. 48. Goncalves KA, Silberstein L, Li S, Severe N, Hu MG, Yang H, Scadden DT, Hu GF: Angiogenin Promotes Hematopoietic Regeneration by Dichotomously Regulating Quiescence of Stem and Progenitor Cells. Cell 2016, 166(4):894-906. 49. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR et al: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425(6960):841-846. 50. Asada N, Katayama Y, Sato M, Minagawa K, Wakahashi K, Kawano H, Kawano Y, Sada A, Ikeda K, Matsui T et al: Matrix-embedded osteocytes regulate mobilization of hematopoietic stem/progenitor cells. Cell stem cell 2013, 12(6):737-747. 51. Miyamoto K, Yoshida S, Kawasumi M, Hashimoto K, Kimura T, Sato Y, Kobayashi T, Miyauchi Y, Hoshi H, Iwasaki R et al: Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. The Journal of experimental medicine 2011, 208(11):2175-2181. 52. Winkler IG, Sims NA, Pettit AR, Barbier V, Nowlan B, Helwani F, Poulton IJ, van Rooijen N, Alexander KA, Raggatt LJ et al: Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116(23):4815-4828. 53. Chow A, Lucas D, Hidalgo A, Mendez-Ferrer S, Hashimoto D, Scheiermann C, Battista M, Leboeuf M, Prophete C, van Rooijen N et al: Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. The Journal of experimental medicine 2011, 208(2):261-271. 54. Christopher MJ, Rao M, Liu F, Woloszynek JR, Link DC: Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. The Journal of experimental medicine 2011, 208(2):251-260. 55. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F: Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 1995, 375(6529):316-318. 56. Perkins AC, Sharpe AH, Orkin SH: Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 1995, 375(6529):318-322. 57. Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A: Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000, 13(2):167-177. 58. Starck J, Cohet N, Gonnet C, Sarrazin S, Doubeikovskaia Z, Doubeikovski A, Verger A, Duterque-Coquillaud M, Morle F: Functional cross-antagonism between transcription factors FLI-1 and EKLF. Molecular and cellular biology 2003, 23(4):1390-1402. 59. Bouilloux F, Juban G, Cohet N, Buet D, Guyot B, Vainchenker W, Louache F, Morle F: EKLF restricts megakaryocytic differentiation at the benefit of erythrocytic differentiation. Blood 2008, 112(3):576-584. 60. Arinobu Y, Mizuno S, Chong Y, Shigematsu H, Iino T, Iwasaki H, Graf T, Mayfield R, Chan S, Kastner P et al: Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell stem cell 2007, 1(4):416-427. 61. Chou ST, Khandros E, Bailey LC, Nichols KE, Vakoc CR, Yao Y, Huang Z, Crispino JD, Hardison RC, Blobel GA et al: Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. Blood 2009, 114(5):983-994. 62. Nerlov C, Graf T: PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes & development 1998, 12(15):2403-2412. 63. Wontakal SN, Guo X, Smith C, MacCarthy T, Bresnick EH, Bergman A, Snyder MP, Weissman SM, Zheng D, Skoultchi AI: A core erythroid transcriptional network is repressed by a master regulator of myelo-lymphoid differentiation. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(10):3832-3837. 64. Evans T, Felsenfeld G: The erythroid-specific transcription factor Eryf1: a new finger protein. Cell 1989, 58(5):877-885. 65. Tsai SF, Martin DI, Zon LI, D'Andrea AD, Wong GG, Orkin SH: Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 1989, 339(6224):446-451. 66. Orkin SH: GATA-binding transcription factors in hematopoietic cells. Blood 1992, 80(3):575-581. 67. Charron F, Nemer M: GATA transcription factors and cardiac development. Seminars in cell & developmental biology 1999, 10(1):85-91. 68. Johnson KD, Kong G, Gao X, Chang YI, Hewitt KJ, Sanalkumar R, Prathibha R, Ranheim EA, Dewey CN, Zhang J et al: Cis-regulatory mechanisms governing stem and progenitor cell transitions. Science advances 2015, 1(8):e1500503. 69. Bresnick EH, Lee HY, Fujiwara T, Johnson KD, Keles S: GATA switches as developmental drivers. The Journal of biological chemistry 2010, 285(41):31087-31093. 70. Katsumura KR, Ong IM, DeVilbiss AW, Sanalkumar R, Bresnick EH: GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells. Cell Rep 2016, 16(9):2428-2441. 71. Cortes-Lavaud X, Maicas M, Vazquez I, Vicente C, Urquiza L, Garcia-Sanchez MA, Odero MD: Functional Analysis of the GATA2 Promoter Shows That Mutations of GATA2 Impair Its Own Transcriptional Regulation. Blood 2012, 120(21):1233-1233. 72. Guo Y, Fu X, Huo B, Wang Y, Sun J, Meng L, Hao T, Zhao ZJ, Hu X: GATA2 regulates GATA1 expression through LSD1-mediated histone modification. American journal of translational research 2016, 8(5):2265-2274. 73. Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH: GATA-1-dependent transcriptional repression of <em>GATA-2</em> via disruption of positive autoregulation and domain-wide chromatin remodeling. Proceedings of the National Academy of Sciences 2003, 100(15):8811-8816. 74. Suzuki M, Kobayashi-Osaki M, Tsutsumi S, Pan X, Ohmori S, Takai J, Moriguchi T, Ohneda O, Ohneda K, Shimizu R et al: GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation. Genes to cells : devoted to molecular & cellular mechanisms 2013, 18(11):921-933. 75. Luc S, Buza-Vidas N, Jacobsen SE: Delineating the cellular pathways of hematopoietic lineage commitment. Seminars in immunology 2008, 20(4):213-220. 76. Lin KH, Li MW, Chang YC, Lin YN, Ho YH, Weng WC, Huang CJ, Chang BE, Yao CL, Lee H: Activation of Lysophosphatidic Acid Receptor 3 Inhibits Megakaryopoiesis in Human Hematopoietic Stem Cells and Zebrafish. Stem cells and development 2018, 27(3):216-224. 77. Chasis JA, Prenant M, Leung A, Mohandas N: Membrane assembly and remodeling during reticulocyte maturation. Blood 1989, 74(3):1112-1120. 78. Gronowicz G, Swift H, Steck TL: Maturation of the reticulocyte in vitro. Journal of cell science 1984, 71:177-197. 79. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995, 83(1):59-67. 80. Muller-Newen G, Stope MB, Kraus T, Ziegler P: Development of platelets during steady state and inflammation. Journal of leukocyte biology 2017. 81. Pang L, Weiss MJ, Poncz M: Megakaryocyte biology and related disorders. The Journal of clinical investigation 2005, 115(12):3332-3338. 82. Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P: Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995, 85(2):402-413. 83. Papadantonakis N, Matsuura S, Ravid K: Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection. Blood 2012, 120(9):1774-1781. 84. Hancock V, Martin JF, Lelchuk R: The relationship between human megakaryocyte nuclear DNA content and gene expression. British journal of haematology 1993, 85(4):692-697. 85. Falcieri E, Bassini A, Pierpaoli S, Luchetti F, Zamai L, Vitale M, Guidotti L, Zauli G: Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. The Anatomical record 2000, 258(1):90-99. 86. Undi RB, Kandi R, Gutti RK: MicroRNAs as Haematopoiesis Regulators. Advances in hematology 2013, 2013:695754. 87. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN et al: LPA receptors: subtypes and biological actions. Annual review of pharmacology and toxicology 2010, 50:157-186. 88. Tigyi G, Miledi R: Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. The Journal of biological chemistry 1992, 267(30):21360-21367. 89. Contos JJ, Ishii I, Chun J: Lysophosphatidic acid receptors. Molecular pharmacology 2000, 58(6):1188-1196. 90. Tigyi GJ, Yue J, Norman DD, Szabo E, Balogh A, Balazs L, Zhao G, Lee SC: Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis. Advances in biological regulation 2019, 71:183-193. 91. Mills GB, Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nature reviews Cancer 2003, 3(8):582-591. 92. Lidgerwood GE, Pitson SM, Bonder C, Pebay A: Roles of lysophosphatidic acid and sphingosine-1-phosphate in stem cell biology. Progress in lipid research 2018, 72:42-54. 93. Todorova MG, Fuentes E, Soria B, Nadal A, Quesada I: Lysophosphatidic acid induces Ca2+ mobilization and c-Myc expression in mouse embryonic stem cells via the phospholipase C pathway. Cellular signalling 2009, 21(4):523-528. 94. Hsiao C, Lampe M, Nillasithanukroh S, Han W, Lian X, Palecek SP: Human pluripotent stem cell culture density modulates YAP signaling. Biotechnology Journal 2016, 11(5):662-675. 95. Qin H, Hejna M, Liu Y, Percharde M, Wossidlo M, Blouin L, Durruthy-Durruthy J, Wong P, Qi Z, Yu J et al: YAP Induces Human Naive Pluripotency. Cell Reports 2016, 14(10):2301-2312. 96. Evseenko D, Latour B, Richardson W, Corselli M, Sahaghian A, Cardinal S, Zhu Y, Chan R, Dunn B, Crooks GM: Lysophosphatidic acid mediates myeloid differentiation within the human bone marrow microenvironment. PloS one 2013, 8(5):e63718. 97. Lin K-H, Ho Y-H, Chiang J-C, Li M-W, Lin S-H, Chen W-M, Chiang C-L, Lin Y-N, Yang Y-J, Chen C-N et al: Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis. Scientific Reports 2016, 6:27050. 98. Chiang CL, Chen SS, Lee SJ, Tsao KC, Chu PL, Wen CH, Hwang SM, Yao CL, Lee H: Lysophosphatidic acid induces erythropoiesis through activating lysophosphatidic acid receptor 3. Stem cells (Dayton, Ohio) 2011, 29(11):1763-1773. 99. Ho YH, Yao CL, Lin KH, Hou FH, Chen WM, Chiang CL, Lin YN, Li MW, Lin SH, Yang YJ et al: Opposing regulation of megakaryopoiesis by LPA receptors 2 and 3 in K562 human erythroleukemia cells. Biochimica et biophysica acta 2015, 1851(2):172-183. 100. Pyne S, Kong KC, Darroch PI: Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. Seminars in cell & developmental biology 2004, 15(5):491-501. 101. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K: Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. The Journal of biological chemistry 2002, 277(42):39436-39442. 102. Nakanaga K, Hama K, Aoki J: Autotaxin--an LPA producing enzyme with diverse functions. Journal of biochemistry 2010, 148(1):13-24. 103. Yang F, Chen GX: Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis. World journal of gastroenterology 2018, 24(36):4132-4151. 104. Ortlepp C, Steudel C, Heiderich C, Koch S, Jacobi A, Ryser M, Brenner S, Bornhauser M, Brors B, Hofmann WK et al: Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation. Experimental hematology 2013, 41(5):444-461.e444. 105. Ray R, Rai V: Lysophosphatidic acid converts monocytes into macrophages in both mice and humans. Blood 2017, 129(9):1177-1183. 106. Kime C, Sakaki-Yumoto M, Goodrich L, Hayashi Y, Sami S, Derynck R, Asahi M, Panning B, Yamanaka S, Tomoda K: Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program. Proceedings of the National Academy of Sciences of the United States of America 2016, 113(44):12478-12483. 107. Bradley RM, Marvyn PM, Aristizabal Henao JJ, Mardian EB, George S, Aucoin MG, Stark KD, Duncan RE: Acylglycerophosphate acyltransferase 4 (AGPAT4) is a mitochondrial lysophosphatidic acid acyltransferase that regulates brain phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol levels. Biochimica et biophysica acta 2015, 1851(12):1566-1576. 108. Sinderewicz E, Grycmacher K, Boruszewska D, Kowalczyk-Zieba I, Staszkiewicz-Chodor J, Lukaszuk K, Woclawek-Potocka I: Expression of genes for enzymes synthesizing lysophosphatidic acid, its receptors and follicle developmental factors derived from the cumulus-oocyte complex is dependent on the ovarian follicle type in cows. Animal reproduction science 2018, 192:242-250. 109. Abu El-Asrar AM, Mohammad G, Nawaz MI, Siddiquei MM, Kangave D, Opdenakker G: Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy. Acta diabetologica 2013, 50(3):363-371. 110. Smyth SS, Mueller P, Yang F, Brandon JA, Morris AJ: Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 2014, 34(3):479-486. 111. Kihara Y, Maceyka M, Spiegel S, Chun J: Lysophospholipid receptor nomenclature review: IUPHAR Review 8. British Journal of Pharmacology 2014, 171(15):3575-3594. 112. Hecht JH, Weiner JA, Post SR, Chun J: Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. The Journal of cell biology 1996, 135(4):1071-1083. 113. Janssens R, Boeynaems JM, Godart M, Communi D: Cloning of a human heptahelical receptor closely related to the P2Y5 receptor. Biochemical and biophysical research communications 1997, 236(1):106-112. 114. Ishii I, Contos JJA, Fukushima N, Chun J: Functional comparisons of the lysophosphatidic acid receptors, LP(A1)NVZG-1/EDG-2, LPA2/EDG-4, and LPA3/EDG-7 in neuronal cell lines using a retrovirus expression system. Molecular pharmacology 2000, 58(5):895-902. 115. An S, Bleu T, Hallmark OG, Goetzl EJ: Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. The Journal of biological chemistry 1998, 273(14):7906-7910. 116. Ishii I, Contos JJ, Fukushima N, Chun J: Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Molecular pharmacology 2000, 58(5):895-902. 117. Lee CW, Rivera R, Dubin AE, Chun J: LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. Journal of Biological Chemistry 2007, 282(7):4310-4317. 118. Lee CW, Rivera R, Gardell S, Dubin AE, Chun J: GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. Journal of Biological Chemistry 2006, 281(33):23589-23597. 119. Pasternack SM, von Kugelgen I, Al Aboud K, Lee YA, Ruschendorf F, Voss K, Hillmer AM, Molderings GJ, Franz T, Ramirez A et al: G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nature genetics 2008, 40(3):329-334. 120. Estivill-Torrus G, Llebrez-Zayas P, Matas-Rico E, Santin L, Pedraza C, De Diego I, Del Arco I, Fernandez-Llebrez P, Chun J, De Fonseca FR: Absence of LPA(1) signaling results in defective cortical development. Cerebral Cortex 2008, 18(4):938-950. 121. Ye XQ, Hama K, Contos JJA, Anliker B, Inoue A, Skinner MK, Suzuki H, Amano T, Kennedy G, Arai H et al: LPA(3)-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 2005, 435(7038):104-108. 122. Lee Z, Cheng CT, Zhang HL, Subler MA, Wu JH, Mukherjee A, Windle JJ, Chen CK, Fang XJ: Role of LPA(4)/p2y9/GPR23 in Negative Regulation of Cell Motility. Molecular Biology of the Cell 2008, 19(12):5435-5445. 123. Ohuchi H, Hamada A, Matsuda H, Takagi A, Tanaka M, Aoki J, Arai H, Noji S: Expression patterns of the lysophospholipid receptor genes during mouse early development. Developmental dynamics : an official publication of the American Association of Anatomists 2008, 237(11):3280-3294. 124. Araki M, Kitayoshi M, Dong Y, Hirane M, Ozaki S, Mori S, Fukushima N, Honoki K, Tsujiuchi T: Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells. Growth factors (Chur, Switzerland) 2014, 32(3-4):117-122. 125. Qin H, Hejna M, Liu Y, Percharde M, Wossidlo M, Blouin L, Durruthy-Durruthy J, Wong P, Qi Z, Yu J et al: YAP Induces Human Naive Pluripotency. Cell reports 2016, 14(10):2301-2312. 126. Todorova MG, Fuentes E, Soria B, Nadal A, Quesada I: Lysophosphatidic acid induces Ca2+ mobilization and c-Myc expression in mouse embryonic stem cells via the phospholipase C pathway. Cellular signalling 2009, 21(4):523-528. 127. Pebay A, Bonder CS, Pitson SM: Stem cell regulation by lysophospholipids. Prostaglandins & Other Lipid Mediators 2007, 84(3-4):83-97. 128. Song HY, Lee MJ, Kim MY, Kim KH, Lee IH, Shin SH, Lee JS, Kim JH: Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis. Biochimica et biophysica acta 2010, 1801(1):23-30. 129. Ryu JM, Han HJ: Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3beta/beta-catenin and PKC/Rho GTPase pathways. Stem cells (Dayton, Ohio) 2015, 33(3):819-832. 130. Grisanti L, Rezza A, Clavel C, Sennett R, Rendl M: Enpp2/Autotaxin in dermal papilla precursors is dispensable for hair follicle morphogenesis. The Journal of investigative dermatology 2013, 133(10):2332-2339. 131. Liu YB, Kharode Y, Bodine PVN, Yaworsky PJ, Robinson JA, Billiard J: LPA Induces Osteoblast Differentiation Through Interplay of Two Receptors: LPA1 and LPA4. Journal of Cellular Biochemistry 2010, 109(4):794-800. 132. Kang S, Han J, Song SY, Kim WS, Shin S, Kim JH, Ahn H, Jeong JH, Hwang SJ, Sung JH: Lysophosphatidic acid increases the proliferation and migration of adiposederived stem cells via the generation of reactive oxygen species. Molecular medicine reports 2015, 12(4):5203-5210. 133. Do EK, Kim YM, Heo SC, Kwon YW, Shin SH, Suh DS, Kim KH, Yoon MS, Kim JH: Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth. The international journal of biochemistry & cell biology 2012, 44(11):2069-2076. 134. Matsushita T, Amagai Y, Soga T, Terai K, Obinata M, Hashimoto S: A novel oligodendrocyte cell line OLP6 shows the successive stages of oligodendrocyte development: late progenitor, immature and mature stages. Neuroscience 2005, 136(1):115-121. 135. Wheeler NA, Lister JA, Fuss B: The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation. The Journal of neuroscience : the official journal of the Society for Neuroscience 2015, 35(32):11399-11414. 136. Rhee HJ, Nam JS, Sun Y, Kim MJ, Choi HK, Han DH, Kim NH, Huh SO: Lysophosphatidic acid stimulates cAMP accumulation and cAMP response element-binding protein phosphorylation in immortalized hippocampal progenitor cells. Neuroreport 2006, 17(5):523-526. 137. Walker TL, Overall RW, Vogler S, Sykes AM, Ruhwald S, Lasse D, Ichwan M, Fabel K, Kempermann G: Lysophosphatidic Acid Receptor Is a Functional Marker of Adult Hippocampal Precursor Cells. Stem cell reports 2016, 6(4):552-565. 138. Dottori M, Leung J, Turnley AM, Pebay A: Lysophosphatidic acid inhibits neuronal differentiation of neural stem/progenitor cells derived from human embryonic stem cells. Stem Cells 2008, 26(5):1146-1154. 139. Frisca F, Crombie DE, Dottori M, Goldshmit Y, Pebay A: Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid. Journal of lipid research 2013, 54(5):1192-1206. 140. Grey A, Chen Q, Callon K, Xu X, Reid IR, Cornish J: The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase. Endocrinology 2002, 143(12):4755-4763. 141. Yao S, Zhang Y, Wang X, Zhao F, Sun M, Zheng X, Dong H, Guo K: Pigment Epithelium-Derived Factor (PEDF) Protects Osteoblastic Cell Line from Glucocorticoid-Induced Apoptosis via PEDF-R. International journal of molecular sciences 2016, 17(5). 142. Karagiosis SA, Karin NJ: Lysophosphatidic acid induces osteocyte dendrite outgrowth. Biochemical and biophysical research communications 2007, 357(1):194-199. 143. David M, Machuca-Gayet I, Kikuta J, Ottewell P, Mima F, Leblanc R, Bonnelye E, Ribeiro J, Holen I, Lopez Vales R et al: Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity. The Journal of biological chemistry 2014, 289(10):6551-6564. 144. Kanehira M, Kikuchi T, Ohkouchi S, Shibahara T, Tode N, Santoso A, Daito H, Ohta H, Tamada T, Nukiwa T: Targeting lysophosphatidic acid signaling retards culture-associated senescence of human marrow stromal cells. PloS one 2012, 7(2):e32185. 145. Igarashi H, Akahoshi N, Ohto-Nakanishi T, Yasuda D, Ishii S: The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells. Scientific reports 2015, 5:11410. 146. Seitz G, Boehmler AM, Kanz L, Mohle R: The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cells. Annals of the New York Academy of Sciences 2005, 1044:84-89. 147. Whetton AD, Lu Y, Pierce A, Carney L, Spooncer E: Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1. Blood 2003, 102(8):2798-2802. 148. Kostic I, Fidalgo-Carvalho I, Aday S, Vazao H, Carvalheiro T, Graos M, Duarte A, Cardoso C, Goncalves L, Carvalho L et al: Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions. Sci Rep 2015, 5:16406. 149. Yanai N, Matsui N, Furusawa T, Okubo T, Obinata M: Sphingosine-1-phosphate and lysophosphatidic acid trigger invasion of primitive hematopoietic cells into stromal cell layers | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21426 | - |
dc.description.abstract | 水解磷酸脂 (Lysophosphatidic acid, LPA) 是由細胞膜上面分離出來的一種小分 子水解磷脂質。經由活化細胞膜上面不同種類的水解磷酸脂受器,會在體內會產 生各式各樣的生理作用。在本研究當中,我們利用四種不同的實驗模式來對水解 磷酸脂受器進行分化的研究。結果發現水解磷酸脂受器二型會抑制紅血球之分化。 相反地,受器三型會促進紅血球之分化。另外一方面,因為紅血球和血小板來自 同一個前趨細胞 Megakaryocyte/erythroid progenitor (MEP),因此我們想探討水解 磷酸脂對於血小板分化路徑之調控。研究結果發現,受器三型在血小板分化的過 程中反而扮演一個抑制分化的角色。我們更發現在不同時期的血球幹細胞,它們 的受器二型和三型的表現量有相當大的差異,而此表現之形式跟 GATA 因子的 表現量具有一定程度的重疊性。研究結果也顯示水解磷酸脂受器二型和三型的表 現量確實是經由 GATA 因子所調控,而在受器二型和三型的啟動子區域也確實 有 GATA 因子的接合位置。經由染色質免疫沈澱的結果也指出 GATA 因子確實 會接合到這些位置上,進而調控受器二型和三型的表現。這些研究結果應可對紅 血球或血小板相關疾病治療提供重要背景知識。 | zh_TW |
dc.description.abstract | Lysophosphatidic acid (LPA) is a membrane-derived lysophospholipid that exists in plasma and platelet. It exerts its functions through activating various LPA receptors (LPARs), which belong to the family of G-protein coupled receptors (GPCRs). Activation of LPARs has been implicated for important roles during stem cell differentiation. However, how LPA affects human hematopoietic stem cell (HSC) differentiation and underlying lineages remains elusive. In our previous studies, we have demonstrated that activation of LPA receptor 3 (LPA3) promotes erythropoiesis in human HSC and zebrafish. In the present study, pharmacological approach was adopted to further elucidate the functions of LPA receptors during red blood cell (RBC) differentiation. Treatment of LPA2 agonist DMP and GRI977143 suppressed erythropoiesis, whereas activation of LPA3 by 2S-OMPT promoted RBC differentiation both in vitro (K562 and HSC) and in vivo (zebrafish and mice). Furthermore, our results demonstrated a negative role of LPA3 during platelet differentiation both in vitro and in vivo. Moreover, the expression pattern of LPA receptors correlated to the hematopoietic transcriptional factors GATA1 and GATA2 in different stages of myeloid progenitors. In addition, manipulation of these GATA factors affected the expression level of LPA2 and LPA3. By luciferase assays, we demonstrated that the promoter region of LPAR2 and LPAR3 were regulated by these GATA factors. Mutation of identified GATA-Binding-Sites (GBS) in the region abrogate the luciferase activities, suggested that LPA2 and LPA3 are transcriptionally regulated by GATA factors. In addition, chromatin immunoprecipitation assays confirmed the directly interaction between GATA factors and promoter region of LPARs. Taken together, our results suggested that the expression level of LPA2 and LPA3, which may be determined by GATA factors, is a regulatory switch for the lineage commitment in myeloid progenitors. The pharmacological activation of LPA receptor subtypes represents a novel strategy for regulating erythropoiesis. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T03:33:45Z (GMT). No. of bitstreams: 1 ntu-108-D03b21006-1.pdf: 15633592 bytes, checksum: a54c789b598ef222d4089f2c61b1c589 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 中文摘要 ..................................................................................... I
Abstract ......................................................................................II Table of contents ....................................................................... IV List of figures ............................................................................ VI Chapter I. Introduction................................................................1 Hematopoiesis ...........................................................................2 Origin of hematopoiesis..............................................................2 Regulation of hematopoiesis.......................................................4 Erythropoiesis and megakaryopoiesis.........................................11 Lysophosphatidic acid.................................................................13 LPA metabolism ..........................................................................14 LPA receptors..............................................................................15 LPA signaling and stem cell differentiation .................................17 Microenvironmental and intracellular effects of LPA during hematopoiesis .18 Specific aims ..............................................................................22 Chapter II. Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis ............................................................................23 Introduction ...............................................................................24 Results .......................................................................................26 Figures ...................................................................................... 33 Chapter III. Activation of Lysophosphatidic Acid Receptor 3 Inhibits Megakaryopoiesis in Human Hematopoietic Stem Cells and Zebrafish ....................................................................................................45 Introduction ................................................................................46 Results ........................................................................................47 Figures ....................................................................................... 52 Chapter IV. Transcriptional regulation of lysophosphatidic acid receptors regulates differentiation of hematopoietic stem cell in myeloid lineage ....................................................................................................62 Introduction ................................................................................63 Results ........................................................................................64 Figures ........................................................................................ 69 Chapter V. Discussion...................................................................87 Chapter VI. Material and Methods................................................103 Reference ....................................................................................116 Appendix | |
dc.language.iso | en | |
dc.title | 水解磷酸脂受器調控血球幹細胞的骨髓分化之研究 | zh_TW |
dc.title | Activation of lysophosphatidic acid receptors regulates differentiation of hematopoietic stem cells in
myeloid lineage | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 姚少凌,黃元勵,蔡素宜,林盈仲 | |
dc.subject.keyword | 水解磷酸脂,造血生成,骨髓分化,貧血, | zh_TW |
dc.subject.keyword | Lysophosphatidic acid,Hematopoiesis,Myeloid differentiation,Anemia, | en |
dc.relation.page | 175 | |
dc.identifier.doi | 10.6342/NTU201902498 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2019-08-06 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生命科學系 | zh_TW |
顯示於系所單位: | 生命科學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 15.27 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。